RecruitingNCT01137825
Registry of Older Patients With Cancer
Carolina Senior: UNC Registry for Older Cancer Patients
Sponsor
UNC Lineberger Comprehensive Cancer Center
Enrollment
3,000 participants
Start Date
Sep 1, 2009
Study Type
OBSERVATIONAL
Conditions
Summary
RATIONALE: Gathering information about older patients with cancer may help the study of cancer in the future. PURPOSE: This research study is gathering information from older patients with cancer into a registry.
Eligibility
Min Age: 65 Years
Inclusion Criteria6
- DISEASE CHARACTERISTICS:
- Patients must have an appointment at the North Carolina Cancer Hospital and agree to complete the Geriatric Assessment NOTE: Not all patients included in the registry will ultimately be diagnosed with cancer. Patients who complete a GA and are not diagnosed with cancer will remain in the database, but will be categorized into a separate group and will not have their medical records accessed.
- PATIENT CHARACTERISTICS:
- Able to read and speak English
- PRIOR CONCURRENT THERAPY:
- Not specified
Locations(7)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01137825
Related Trials
A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies
NCT057965702 locations
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
NCT0685942413 locations
Combined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS
NCT056365145 locations
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
NCT0425631773 locations
CIML NK Cells With Venetoclax for AML
NCT061528092 locations